Involvement of bone morphogenetic protein-binding endothelial regulator in aortic valve stenosis

value and the effect of valsartan. Circulation 2005;112:1428–34. [10] Kai H, Kuwahara F, Tokuda K, Imaizumi T. Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis. Hypertens Res 2005;28:483–90. [11] Westermann D, Lindner D, Kasner M, et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 2011;4:44–52. [12] Jylhava J, Haarala A, Kahonen M, et al. Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: theHealth 2000Survey. ClinExp Immunol 2011;164:211–7. [13] Bottazzi B, Garlanda C, Cotena A, et al. The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunol Rev 2009;227:9–18. [14] Inforzato A, Jaillon S, Moallie F, et al. The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodeling. Tissue Antigens 2011;77:271–82 4. [15] Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149–50.